Differential effects of estrogen and progesterone on AT1 receptor gene expression in vascular smooth muscle cells

Circulation

Volumn 102, Issue 15, 2000, Pages 1828-1833

  Nickenig, Georg ^a   Strehlow, Kerstin ^a   Wassmann, Sven ^a   Bäumer, Anselm T ^a   Albory, Katja ^a   Sauer, Heinrich ^a   Böhm, Michael ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Angiotensin; Atherosclerosis; Hormones; Hypertension; Muscle, smooth; Receptors

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ESTRADIOL; MESSENGER RNA; PROGESTERONE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; GENE OVEREXPRESSION; HORMONAL REGULATION; HORMONE ACTION; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR GENE; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0034633808     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.15.1828     Document Type: Article

References (29)

1. Cardiovascular health and disease in women
2. Menopause and the risk of coronary heart disease in women
3. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women
4. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women
5. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: The Atherosclerosis Risk in Communities Study
6. The effect of estriol succinate therapy on plasma renin activity and urinary aldosterone in postmenopausal women
7. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women
8. Antioxidant and prooxidant properties of estrogens
9. 2+ uptake
10. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro
11. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
12. 2+ mobilization
13. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
14. Progestin enhances vasoconstrictor responses in post menopausal women receiving estrogen replacement therapy
15. Medroxiprogesterone interferes with ovarian steroid protection against coronary vasospasm
16. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
17. How progestins compromise the cardioprotective effects of estrogens
18. Molecular biology of the renin-angiotensin system
19. 1 receptor gene expression in vitro and in vivo
20. The protective effects of estrogen on the cardiovascular system
21. 1 receptor mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells
22. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression
23. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells
24. 1 receptor gene expression by posttranscriptional mechanisms
25. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
26. Regulation of vascular type 1 angiotensin receptors by cytokines
27. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide
28. Nitric oxide (NO) upregulates NO synthase expression in fetal intrapulmonary artery endothelial cells
29. Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women